Male Breast Cancer Terminated Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000958883-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTreatment